Xenetic Biosciences (XBIO) Non-Current Deferred Tax Liability (2014 - 2021)

Xenetic Biosciences (XBIO) has 7 years of Non-Current Deferred Tax Liability data on file, last reported at $17082.0 in Q4 2020.

• Quarterly Non-Current Deferred Tax Liability fell 99.42% year-over-year to $17082.0 in Q4 2020, while the trailing twelve-month figure through Dec 2020 was $17082.0 (down 99.42% YoY) and the FY2020 annual result came in at $17082.0, down 99.42% from the prior year.
• Non-Current Deferred Tax Liability declined to $17082.0 in Q4 2020, from $2.9 million in the prior quarter.
• In the past five years, Non-Current Deferred Tax Liability ranged from a high of $2.9 million in Q4 2019 to a low of $17082.0 in Q4 2020.
• A 5-year average of $2.8 million and a median of $2.9 million in 2016 frame the typical range for Non-Current Deferred Tax Liability.
• Annual changes were most pronounced in 2019 — Non-Current Deferred Tax Liability climbed 0.19% — and 2020, when it slumped 99.42%.
• Tracing XBIO's Non-Current Deferred Tax Liability over 5 years: stood at $2.9 million in 2016, then changed by 0.0% to $2.9 million in 2017, then changed by 0.0% to $2.9 million in 2018, then rose by 0.19% to $2.9 million in 2019, then tumbled by 99.42% to $17082.0 in 2020.
• The last three Non-Current Deferred Tax Liability figures came in at $17082.0 (Q4 2020), $2.9 million (Q2 2020), and $2.9 million (Q1 2020), per Business Quant data.